NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is…
NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in…
NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than…
NEW YORK (Reuters Health) – Patients with NYHA class II heart failure are less likely to develop atrial fibrillation or flutter when given eplerenone, according to findings appearing…
NEW YORK (Reuters Health) – Despite a guideline in Canada recommending the use of opioids to relieve refractory dyspnea in COPD patients, physicians there are reluctant to do…
NEW YORK (Reuters Health) – Cancer patients given pegfilgrastim experience less bone pain if they take naproxen 500 mg twice daily for about a week, according to the…
Early neurologic outcomes are better with conventional carotid endarterectomy (CEA) than eversion CEA, but the eversion technique may be more effective for preventing stroke over the long term,…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy for HER2-positive early breast cancer significantly reduces recurrence risk and improves overall survival, but it also increases…
NEW YORK (Reuters Health) – Among older patients with an intact abdominal aortic aneurysm (AAA), those undergoing endovascular repair have a lower long-term mortality risk than those undergoing…
NEW YORK (Reuters Health) – Adding cladribine to the standard induction regimen for adults with acute myeloid leukemia (AML) increases the complete remission rate and consequent survival, a…